In the present investigation, expressions of efflux transporters in various tumor cells are determined and the cell-killing effects of brentuximab vedotin and MMAE are evaluated through modulating P-gp-MDR1 activities and lysosomal functions. The gene discussed is PGP; the disease is neoplasm.